GlassScriptDxi 9000 Access Immunoassay Analyzer
Payments companies reported to CMS as associated with Dxi 9000 Access Immunoassay Analyzer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dxi 9000 Access Immunoassay Analyzer, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dxi 9000 Access Immunoassay Analyzer
These are the largest totals companies reported as associated with Dxi 9000 Access Immunoassay Analyzer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Harvey | Annapolis, MD | Internal Medicine | $106,500.00 |
| Daniel Spyker | Camas, WA | Internal Medicine | $39,130.00 |
| Jason Freed | Boston, MA | Hematology (Internal Medicine) | $18,000.00 |
| Jason Moran | South Portland, ME | Hematology & Oncology | $18,000.00 |
| Kelly Graham | Boston, MA | Internal Medicine | $17,000.00 |
| Shreya Trivedi | Boston, MA | Hospitalist | $16,000.00 |
| Peng Ji | Chicago, IL | Clinical Pathology | $11,000.00 |
| Samir Parikh | Dallas, TX | Nephrology (Internal Medicine) | $8,500.00 |
| Holleh Husseinzadeh | Philadelphia, PA | Hematology & Oncology | $8,250.00 |
| David Wolk | Philadelphia, PA | Neurology (Psychiatry & Neurology) | $8,180.00 |
Prescribed Dxi 9000 Access Immunoassay Analyzer?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.